Hospital Pre-discharge Education Improves Home Infusion Outcomes, Option Care Study Shows


Anti-infective Home Infusion Patients Who Receive RN-provided Education Less Likely to be Readmitted to Hospital, Experience Therapy Disruption, Suggests Research Presented at NHIA Meeting


BANNOCKBURN, Ill., June 12, 2017 – Patients have better outcomes when provided anti-infective home infusion education prior to discharge from the hospital, suggests Option Care data presented at the 2017 National Home Infusion Association (NHIA) Annual Conference & Exposition. Patients who received pre-discharge education from a registered nurse clinical liaison were less likely to experience disruptions in home infusion therapy, go to the emergency room or be readmitted to the hospital, the study found.

While hospitals provide general pre-discharge education, it typically covers everything related to leaving the hospital, including oral medications and follow-up appointments, and may only briefly address home infusion. Often the hospital nurse providing the education has limited knowledge of home infusion and therefore may not provide adequate information to prepare the patient. Conversely, a home infusion clinical liaison nurse visits the patient several days before the scheduled discharge to fully explain and demonstrate home infusion care and, when possible, makes additional visits to be sure questions are answered and all caregivers understand the directions.

“The home infusion clinical liaison really helps ease patients’ fears and better prepare them to comfortably and successfully receive home infusion1,” said Nora Bondi, RN, lead author of the study and Option Care’s senior director of operations for North Carolina. “Clinical liaison pre-discharge education is a vital aspect of Option Care’s comprehensive high-touch, high-quality care, which helps ensure patients have more successful outcomes.”

The study compared outcomes of 60 patients who received pre-discharge education, to 37 patients who did not (patients sometimes are hospitalized briefly and released too quickly to receive pre-discharge education).¹ Outcomes improved by 20 percent overall among patients who received pre-discharge education vs. those who did not. Specifically:

  • Made after-hours calls (such as for technical questions/concerns related to therapy, pump or IV access) or experienced interruptions in therapy: 3 percent of patients who received pre-discharge education vs. 51 percent of those who did not.
  • Readmitted to the hospital or visited the emergency room: 20 percent of patients who received pre-discharge education vs. 48 percent of those who did not.
  • Completed therapy without intervention: 68 percent of patients who received pre-discharge education vs. 48 percent of those who did not.

Pre-discharge education provided by the home infusion clinical liaison nurse includes: demonstrating proper handwashing and clean technique for therapy administration in an effort to prevent infection; explaining appropriate care of the medication (such as refrigeration); showing how to care for the intravenous (IV) line and how to monitor for signs of infection; demonstrating how to flush the IV line; demonstrating the actual pump or device to be used in home infusion; and reviewing the medication schedule.

Anti-infectives – including antibiotics, antivirals and antifungals to treat a wide range of infections and infectious diseases – are the most common indication for home infusion therapy.


关于 Option Care

Option Care Enterprises, Inc. (Option Care) 是全美最大和最值得信赖的家庭和备选治疗站点输液服务提供者。作为行业领导者,本公司汲取了近 40 年的临床护理经验,提供以患者为中心的治疗管理。Option Care 的标志性家庭输液+服务包括输液药物的临床管理、护理支持和护理协调。Option Care 由 1,800 多名临床医师(包括药剂师、护士和营养师)组成的多学科团队能够为美国各地需要接受复杂和慢性病治疗的几乎所有患者提供家庭输液服务覆盖。有关详情请访问


Media Contact Information:
Lauren Kotarski


# # #


1.Bondi N and Stancil H. Pre-discharge education by registered nurse clinical liaison improves home infusion outcomes in adult intravenous anti-infective therapy patients. Poster presented at the 2017 National Home Infusion Association (NHIA) Annual Conference & Exposition: May 22-25, 2017; Orlando.